Insider Transactions in Q2 2022 at Longeveron Inc. (LGVN)
Insider Transaction List (Q2 2022)
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Jun 03
2022
|
James Clavijo CFO and Treasurer |
SELL
Open market or private sale
|
Direct |
36,955
-31.7%
|
$295,640
$8.26 P/Share
|
|
Jun 03
2022
|
James Clavijo CFO and Treasurer |
BUY
Grant, award, or other acquisition
|
Direct |
40,000
+25.55%
|
-
|
|
Jun 03
2022
|
Paul T Lehr General Counsel, Secretary |
BUY
Grant, award, or other acquisition
|
Direct |
40,000
+20.88%
|
-
|
|
May 24
2022
|
Rock Soffer |
SELL
Open market or private sale
|
Direct |
4,000
-0.59%
|
$28,000
$7.5 P/Share
|
|
May 23
2022
|
Rock Soffer |
SELL
Open market or private sale
|
Direct |
8,000
-1.17%
|
$56,000
$7.78 P/Share
|
|
May 20
2022
|
Rock Soffer |
SELL
Open market or private sale
|
Direct |
7,500
-1.08%
|
$60,000
$8.06 P/Share
|
|
May 17
2022
|
Rock Soffer |
BUY
Other acquisition or disposition
|
Direct |
500,182
+41.96%
|
-
|
|
May 17
2022
|
Donald M Soffer |
BUY
Other acquisition or disposition
|
Direct |
6,535,223
+49.4%
|
-
|
|
May 17
2022
|
Donald M Soffer |
SELL
Other acquisition or disposition
|
Indirect |
7,024,208
-100.0%
|
-
|
|
May 17
2022
|
Ds Med LLC |
SELL
Other acquisition or disposition
|
Direct |
7,024,208
-100.0%
|
-
|
|
Apr 19
2022
|
Joshua Hare Chief Scientific Officer |
SELL
Open market or private sale
|
Direct |
78
-0.0%
|
$780
$10.0 P/Share
|
|
Apr 18
2022
|
Joshua Hare Chief Scientific Officer |
SELL
Open market or private sale
|
Direct |
19,922
-0.25%
|
$199,220
$10.0 P/Share
|
|
Apr 13
2022
|
Donald M Soffer |
SELL
Other acquisition or disposition
|
Indirect |
748,694
-9.63%
|
-
|
|
Apr 13
2022
|
Rock Soffer |
BUY
Other acquisition or disposition
|
Direct |
139,912
+42.2%
|
-
|
|
Apr 13
2022
|
Ds Med LLC |
SELL
Other acquisition or disposition
|
Direct |
748,694
-9.63%
|
-
|
|
Apr 04
2022
|
James Clavijo CFO and Treasurer |
SELL
Payment of exercise price or tax liability
|
Direct |
1,288
-1.65%
|
$19,320
$15.61 P/Share
|
|
Apr 04
2022
|
Geoff Green CEO |
SELL
Payment of exercise price or tax liability
|
Direct |
1,840
-1.36%
|
$27,600
$15.61 P/Share
|
|
Apr 04
2022
|
Paul T Lehr General Counsel, Secretary |
SELL
Payment of exercise price or tax liability
|
Direct |
1,472
-1.3%
|
$22,080
$15.61 P/Share
|
|
Apr 04
2022
|
Kwan Hong Christopher Min Chief Medical Officer |
BUY
Grant, award, or other acquisition
|
Direct |
152,335
+49.81%
|
-
|